HealthDay on MSN7h
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & Diabetes
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as ...
Health Care Up on GLP-1 Alzheimer's Data -- Health Care Roundup
Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs, rallied ...
Healio8h
Study: GLP-1s ‘hold promise’ for treating a wide range of diseases and health outcomes
Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...
Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
BioSpace9h
The Good, the Bad and the Ugly of GLP-1s: Study
Computational research conducted by scientists from Washington University in St. Louis shows that GLP-1 agonists can have ...
Study reveals GLP-1 drugs’ benefits and risks for users
A study by Washington University School of Medicine and the VA St. Louis Health Care System has found that GLP-1 drugs can have both health benefits and risks, including reduced risks of ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have other untapped potentials to reduce health risks.